Evaluation of biomarkers in VTE study: the EVA study. - the EVA study

niversitair Medisch Centrum Utrecht0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•Patients are eligible for the study if:
•- The general practitioner (GP) has a suspicion of deep venous thrombosis (DVT) or pulmonary embolism (PE), i.e. unexplained pain, swelling, and/or redness of the leg in case of DVT, or unexplained shortness of breath and pain when breathing in case of PE.
•- Patients have a low score on a clinical decision rule (low pre-test probability of DVT or PE), and thus the GP aims to rule-out VTE (if possible) using routine care D-dimer testing.

•Exclusion criteria are:
•- Age below 18.
•- Already using anticoagulant treatment with vitamin K antagonists, Non vitamin K Oral Anti Coagulants (NOAC) and/or low molecular-weight heparin (LMWH).
•- With a non-low score on a clinical decision rule
•- With an already determined POC D-dimer by the GP, suitable for risk stratification
•- Life expectancy less than 3 months.
•- Unwilling to participate with this study (opt-out procedure).

发起方

niversitair Medisch Centrum Utrecht